Brian was appointed CEO designate of Haleon in July 2021, having been CEO of the division since 2016, where he focused on shaping a strategy for growth that puts purpose at its heart. He leads 23,000 employees across more than 100 countries, who are working every day to deliver better everyday health with humanity.
Prior to joining GSK, initially as Head of Europe and the Americas in 2015, Brian spent over a decade at Novartis in senior leadership roles in the Over the Counter (OTC) division. He began his career at Procter & Gamble, where over a 16-year tenure, he gained extensive experience in product supply, brand marketing, and customer leadership.
Brian is a Board member of the Consumer Goods Forum (CGF). He has previously served as a Board Member and Chairman of the Global Self Care Federation (GSCF) and was an active member of the Board of Trustees for Treloar’s – a trust providing support and independence education for young people with physical disabilities.
Favourite brand: Voltaren